Phenobarbital (Luminal) for MERRF Syndrome
|1 Patients Studied||1 Studies (View)|
Definition: Phenobarbital or phenobarbitone is a barbiturate, first marketed as Luminal by Friedr. Bayer et comp. It is the most widely used anticonvulsant worldwide, and the oldest still commonly used. It also has sedative and hypnotic properties but, as with other barbiturates, has been superseded by the benzodiazepines for these indications. MERRF syndrome (or Myoclonic Epilepsy with Ragged Red Fibers) is a mitochondrial disease. It is extremely rare, with an estimated prevalence of 1/400,000 in Europe, and has varying degrees of expressivity owing to heteroplasmy (SOURCE: Wikipedia)
Where does Phenobarbital (Luminal) rank compared to other MERRF Syndrome treatments?
Most Researched Conditions
What other conditions have been studied?
Health experts published 1 study on Phenobarbital for Nutritional and Metabolic Diseases patients suffering from MERRF Syndrome.
What treatments have patients discontinued using?